Gary S. Gillheeney, President and CEO at Organogenesis Holdings Inc. (ORGO), sold 334,322 shares at $5.60 ($1.9M) on 2022-05-25, disclosed to the SEC on 2022-05-25.
Open-market sale of $1.9M ORGO by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.80 | 53,680 | $311K | 16.5% |
| 2 | $5.84 | 6,670 | $39K | 2.1% |
| 3 | $5.66 | 52,312 | $296K | 15.7% |
| 4 | $5.66 | 52,312 | $296K | 15.7% |
| 5 | $5.60 | 84,674 | $474K | 25.1% |
| 6 | $5.60 | 84,674 |
| $474K |
| 25.1% |
| Total | $5.66 avg | 334,322 | $1.9M | 100% |
| Filing → |
| ORGO | SELL | 2024-12-09 | $423K | — | Filing → |
| ORGO | SELL | 2022-06-03 | $2.7M | — | Filing → |
| ORGO | SELL | 2022-05-31 | $2.6M | — | Filing → |